China's Suzhou Abogen Biosciences Co said its COVID-19 vaccine candidate using the messenger RNA (mRNA) technology and targeting the Omicron variant has obtained clinical trial approval in the United Arab Emirates.
China's Shanghai reported zero COVID-19 cases outside its quarantined areas for April 29, the first time since the recent outbreak in the eastern financial hub, according to local health authorities.
The U.S. Justice Department said it filed a complaint on Friday challenging a law in Alabama that criminalizes some gender-affirming treatments for transgender youth.
Pfizer Inc on Friday said a large trial found that its COVID-19 oral antiviral treatment Paxlovid was not effective at preventing coronavirus infection in people living with someone infected with the virus.
Abbott Laboratories said on Friday it would release limited quantities of nutrition products that had been put on hold following a recall of some powdered infant formulas from its Michigan facility.
The UK Health Security Agency has identified 34 confirmed hepatitis cases in children since Monday, bringing the total number to 145 amid a series of unexplained cases among children around the world.
Russia's total number of COVID-related deaths has exceeded 803,000 since the start of the pandemic in April 2020, Reuters calculations based on new data from the Rosstat state statistics service showed on Friday.
Scientists and health officials by this summer should have a better sense of what type of COVID-19 booster will be needed to deal with the next phase of the pandemic and when it should be administered, top U.S. infectious disease expert Dr. Anthony Fauci said on Friday.
Canada is reviewing a request by Moderna to approve its COVID-19 vaccine for pediatric use in children aged 6 months to 5 years, the government and the company said on Friday.
